Research Specifications
- Components:
- Ipamorelin 3mg + Tesamorelin 10mg (13mg total)
- Form:
- Lyophilized co-formulation
- Purity:
- ≥98% HPLC verified (each component)
- Vial:
- 13mg blend
- Storage:
- −20°C long-term / 2–8°C up to 4 weeks reconstituted
Ipamorelin/Tesamorelin Blend 13mg
Trans-3-hexenoyl-GHRH(1-44)-NH2
CAS: 218949-48-5
3mg + 10mg
Per-component mass
13mg total blend
Dual pathway
GHRH + ghrelin
Synergistic GH pulse
2010
Tesamorelin FDA approval
Egrifta label
Receptor Targets
GHRH-RTesamorelin component — FDA-validated GH release
GHSR (Ghrelin-R)Ipamorelin component — selective pulsatile release
$116.99In Stock
Buy Now ≥98% Purity Verified Free Shipping $200+ HPLC Tested
Also Known As
Ipa/Tesa blend 13mgTesamorelin + Ipamorelin stack
Reconstitution & Dosing Guide
BAC Water
2mL
Final Concentration
6.5 mg/mL total (1.5 mg/mL Ipa + 5 mg/mL Tesa)
Per Dose
0.4 mL = ~600 μg Ipa + ~2 mg Tesa (clinical label Tesa ratio)
Pre-sleep dosing aligns with natural nocturnal GH pulse
Often Stacked With
Published References
- 1.Falutz J, Allas S, Blot K, et al.. Metabolic effects of a growth hormone–releasing factor in patients with HIV. NEJM (2007) PMID: 18032764
- 2.Raun K, Hansen BS, Johansen NL, et al.. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology (1998) PMID: 9700374
Research Use Only. This product is intended for in-vitro laboratory research only. Not for human consumption, injection, or therapeutic use. Not medical advice. Always consult applicable regulations in your jurisdiction.
Price Comparison
| Supplier | Purity | Price | Shipping |
|---|---|---|---|
| our verified supplier | >98% HPLC | $116.99 | Free over $200 |
| Generic Research Suppliers | Varies (often <95%) | Similar–Higher | Varies |
| Pharmaceutical (Rx only) | Pharmaceutical grade | Not available for research | Rx required |
Buy Peptides Compounds
Ipamorelin/Tesamorelin Blend 13mg
$116.99